Mast cells: “central regulatory hub” of neuro-endocrine-immune dysregulation in vitiligo - Takeaways - MDSpire

Mast cells: “central regulatory hub” of neuro-endocrine-immune dysregulation in vitiligo

  • By

  • Chen Zhang

  • Zhanhong Cao

  • Yuxin Bai

  • Xuanxuan Zhu

  • Yue Shen

  • Zhenhua Wang

  • Jincai Li

  • Wenjian Wang

  • Meng Zhang

  • June 26, 2026

  • 0 min

Share

  • 1

    Mast cells (MCs) are innate immune cells that mediate interactions between the neuroendocrine and immune systems.

  • 2

    Vitiligo is a complex disorder with multiple pathogenic factors, including genetic susceptibility and neurogenic components.

  • 3

    Current models of vitiligo pathogenesis do not fully account for the role of mast cells in melanocyte dysfunction.

  • 4

    Therapeutic agents targeting mast cells, such as ketotifen and imatinib, have been clinically implemented for vitiligo.

  • 5

    Mast cells exhibit bidirectional interactions with neural and endocrine systems, influencing melanocyte function.

Original Source(s)

Related Content